ROIC_ NEW logo_blue text transparent background.png
Retail Opportunity Investments Corp. Reports 2024 First Quarter Results
23 avr. 2024 16h15 HE | Retail Opportunity Investments Corp.
SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the three months ended March 31, 2024. ...
BioNTech veröffentli
BioNTech veröffentlicht am 6. Mai 2024 Ergebnisse für das erste Quartal 2024 und informiert über operativen Fortschritt
22 avr. 2024 06h45 HE | BioNTech SE
MAINZ, Deutschland, 22. April 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird am Montag, den 6. Mai 2024, die Ergebnisse für das erste Quartal 2024...
BioNTech to Report F
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
22 avr. 2024 06h45 HE | BioNTech SE
MAINZ, Germany, April 22, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2024 on Monday, May 6, 2024....
fortuna.png
Fortuna to release first quarter 2024 financial results on May 7, 2024; Conference call at 12 p.m. Eastern Time on May 8, 2024
22 avr. 2024 05h00 HE | Fortuna Silver Mines Inc.
VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) announces that it will release its unaudited financial statements and MD&A for...
Provident Financial Services, Inc. Logo
Provident Financial Services, Inc. Announces First Quarter Earnings and Declares Quarterly Cash Dividend
18 avr. 2024 17h00 HE | Provident Financial Services, Inc.
ISELIN, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”) reported net income of $32.1 million, or $0.43 per basic and diluted share for the...
Arbutus Biopharma Logo
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
18 avr. 2024 07h30 HE | Arbutus Biopharma Corporation
WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
TriumphFinancial_Logo_FullColor.png
Triumph Financial Releases First Quarter 2024 Financial Results
17 avr. 2024 16h07 HE | Triumph Financial, Inc.
DALLAS, April 17, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) has released its first quarter 2024 financial results. The 1Q 2024 financial results and shareholder letter are...
Provident Financial Services, Inc. Logo
Provident Financial Services, Inc. Schedules First Quarter Earnings Conference Call
11 avr. 2024 09h00 HE | Provident Financial Services, Inc.
ISELIN, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter ended March 31, 2024 on...
TriumphFinancial_Logo_FullColor.png
Triumph Financial Announces Schedule for First Quarter 2024 Earnings Release and Conference Call
05 avr. 2024 16h07 HE | Triumph Financial, Inc.
DALLAS, April 05, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its first quarter financial results and management commentary after the...
Optinose_logo_RGB.png
Optinose to Present at the Needham Virtual Healthcare Conference
04 avr. 2024 16h01 HE | Optinose, Inc.
YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...